The caveat here is that if one is opting for rhythm control to avoid the need for warfarin in this elderly population, that is not a valid assumption. How should one manage atrial fibrillation ...

In the AFFIRM trial, elderly patients (mean age, 70; 61% men) with minimally symptomatic atrial fibrillation (AF) and high risk for stroke were randomized to either a rate-control or a rhythm ...

Researchers sought to determine 1-year outcomes in patients being treated with tirzepatide who have atrial fibrillation.

a “rate control” strategy and a “rhythm control” strategy. In 2002, the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) randomized trial evaluated the outcomes of ...

Stroke, one of the most severe complications of atrial fibrillation (AF), can be prevented by oral anticoagulants in patients ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

(European Journal of Preventive Cardiology) The available observational data point to dronedarone being better than sotalol as a first-line anti-arrhythmic drug for rhythm control in Afib.

You may be able to lower your risk for developing heart rhythm abnormalities by speeding ... Nearly 60 million people worldwide have atrial fibrillation, according to a 2024 study.

Atrial fibrillation (AFib) is the most common abnormal heart rhythm found in our community. According to the CDC website, an estimated 12 million people in the United States will have atrial ...

WASHINGTON, April 23, 2025 /PRNewswire/ -- Today, the Heart Rhythm Society (HRS) released a framework outlining criteria for establishing an Atrial Fibrillation (AF) Center of Excellence (CoE ...

The procedure is becoming physicians’ preferred ablation method for treating atrial fibrillation, an irregular rhythm that can lead to complications such as blood clots, stroke and heart failure.